Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia

被引：0
|
作者：
Hwang, Steven
Wang, Yucai
Rabe, Kari
Williams-Watley, Marquise
Kenderian, Saad
Muchtar, Eli
Hampel, Paul
Kay, Neil
Koehler, Amber
Behnken, Amy
Leis, Jose
Braggio, Esteban
Shi, Min
Viswanatha, David
Van Dyke, Daniel
Slager, Susan
Parikh, Sameer
He, Rong
Ding, Wei
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1550290
引用
收藏
页码：S84 / S85
页数：2
相关论文
共 50 条
  • [1] Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
    Hwang, Steven R.
    Wang, Yucai
    Rabe, Kari G.
    He, Rong
    Kenderian, Saad S.
    Muchtar, Eli
    Hampel, Paul J.
    Kay, Neil E.
    Call, Timothy G.
    Koehler, Amber
    Behnken, Amy L.
    Leis, Jose F.
    Braggio, Esteban
    Shi, Min
    Viswanatha, David S.
    Van Dyke, Daniel L.
    Slager, Susan L.
    Parikh, Sameer A.
    Ding, Wei
    BLOOD, 2022, 140 : 12390 - 12392
  • [2] Prognostic Impact of NOTCH1 Hotspot Mutation in TP53-Mutated Patients with Chronic Lymphocytic Leukemia
    Kantorova, Barbara
    Malcikova, Jitka
    Navrkalova, Veronika
    Smardova, Jana
    Brazdilova, Kamila
    Plevova, Karla
    Diviskova, Eva
    Borsky, Marek
    Pavlova, Sarka
    Tom, Nikola
    Pal, Karol
    Trbusek, Martin
    Oltova, Alexandra
    Brychtova, Yvona
    Doubek, Michael
    Mayer, Jiri
    Pospisilova, Sarka
    BLOOD, 2014, 124 (21)
  • [3] Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib
    Guarini, Anna
    Peragine, Nadia
    Messina, Monica
    Marinelli, Marilisa
    Ilari, Caterina
    Cafforio, Luciana
    Raponi, Sara
    Bonina, Silvia
    Mariglia, Paola
    Mauro, Francesca R.
    Gaidano, Gianluca
    Del Giudice, Ilaria
    Foa, Robin
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (03) : 392 - 396
  • [4] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [5] Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
    Boddu, Prajwal
    Kantarjian, Hagop
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias J.
    Benton, Christopher B.
    DiNardo, Courtney D.
    Konopleva, Marina
    Daver, Naval
    Patel, Keyur
    Takahashi, Koichi
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge
    Kadia, Tapan
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2238 - 2241
  • [6] Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
    Zhang, Lijuan
    Chen, Kankan
    Li, Yingying
    Chen, Qiuni
    Shi, Wenting
    Ji, Tingting
    Tao, Hong
    He, Zhengmei
    Wang, Chunling
    Yu, Liang
    HEMATOLOGY, 2023, 28 (01)
  • [7] Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
    Shallis, Rory M.
    Bewersdorf, Jan P.
    Stahl, Maximilian F.
    Halene, Stephanie
    Zeidan, Amer M.
    CANCERS, 2022, 14 (10)
  • [8] Curcumin Enhances Ibrutinib Induced Killing Effect Against TP53-Mutated Chronic Lymphocytic Leukemia Cells in Vitro
    Zhang, Yunxia
    Lei, Haohao
    Wei, Xiaolei
    Wei, Yongqiang
    Feng, Ru
    Guo, Xutao
    BLOOD, 2023, 142
  • [9] Curcumin enhances ibrutinib induced killing effect against TP53-mutated chronic lymphocytic leukemia cells in vitro
    Zhang, Yunxia
    Guo, Xutao
    Feng, Ru
    Wei, Xiaolei
    Wei, Yongqiang
    Lei, Haohao
    LEUKEMIA & LYMPHOMA, 2023, 64 : S118 - S119
  • [10] Treatment approaches for patients with TP53-mutated mantle cell lymphoma
    Lew, Thomas E.
    Minson, Adrian
    Dickinson, Michael
    Handunnetti, Sasanka M.
    Blombery, Piers
    Khot, Amit
    Anderson, Mary Ann
    Ritchie, David
    Tam, Constantine S.
    Seymour, John F.
    LANCET HAEMATOLOGY, 2023, 10 (02): : E142 - E154
12345